Skip to main content
Kindstar Globalgene Technology, Inc. logo

Kindstar Globalgene Technology, Inc. — Investor Relations & Filings

Ticker · 9960 ISIN · KYG5262E1044 HKEX Human health and social work activities
Open in API
Filings indexed 603 across all filing types
Latest filing 2023-06-20 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 9960

About Kindstar Globalgene Technology, Inc.

http://www.kindstar.com.cn

Kindstar Globalgene Technology, Inc. is a leading independent provider of advanced specialty clinical testing services, specializing in esoteric testing. The company maintains the largest esoteric testing portfolio in its market, utilizing internationally-advanced laboratory facilities for clinical testing, scientific research, and applied R&D. Its comprehensive testing menu, featuring over 100 items, covers critical diagnostic areas including hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology. These services provide physicians and patients access to specialized diagnostics crucial for the diagnosis and treatment of major diseases.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Returns
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It references specific rules from the Hong Kong Stock Exchange (Main Board Listing Rules and GEM Listing Rules) and details numerous repurchases of shares with dates and quantities. The content is a detailed regulatory disclosure of share repurchase activity, not a financial report or earnings release. It is not a report publication announcement or a certification letter but a formal regulatory filing about share capital changes. This fits the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares (share repurchase/issuance). The document length (15,000 characters) and detailed data support this classification with high confidence.
2023-06-20 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It includes detailed tables of repurchase of shares with dates and quantities, confirming compliance with listing rules of the Hong Kong Stock Exchange. The content is focused on reporting share repurchase activities and changes in issued shares, which aligns with announcements regarding share repurchases or capital changes. The document is lengthy (15,000 characters) and contains detailed transactional data, not just a brief announcement or a certification. Therefore, it is not a simple Regulatory Filing or Report Publication Announcement. The document fits best under the category of 'Transaction in Own Shares' (POS), which covers reports of the company buying back or selling its own shares (share repurchase/issuance).
2023-06-19 English
DISCLOSEABLE TRANSACTION - FORMATION OF PARTNERSHIP
Capital/Financing Update Classification · 95% confidence The document is an announcement by Kindstar Globalgene Technology, Inc. regarding the formation of a partnership involving capital contributions and investment management arrangements. It details the terms of the partnership agreement, parties involved, capital contributions, management structure, and regulatory implications under the Hong Kong Listing Rules. The document is a formal disclosure of a transaction that meets the criteria of a discloseable transaction under Chapter 14 of the Listing Rules, indicating it is a capital or financing related update. There is no indication that this is a full financial report, earnings release, or other types of filings such as management reports or legal proceedings. The document is lengthy (15,000 characters) and contains substantive details about the transaction, not merely an announcement of a report publication. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2023-06-18 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It contains detailed tabular data on repurchases of shares over various dates, confirming compliance with listing rules and legal requirements. The content focuses on share repurchase activities and changes in issued share capital, which aligns with announcements regarding share buybacks or capital changes. There is no indication of financial statements, management discussion, or earnings data. The document is not a report but a regulatory disclosure of share repurchase transactions. Therefore, it fits the category of 'Transaction in Own Shares' (POS). The document length is substantial and contains detailed transactional data, supporting a high confidence in classification.
2023-06-14 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It details numerous repurchases of shares over a period, with dates and quantities, and includes confirmations related to share issues and repurchases. The document references compliance with listing rules and legal requirements for share capital changes. This type of document is a formal notification of share repurchase activity and changes in capital structure, not a full financial report or earnings release. It fits the category of 'Transaction in Own Shares' which covers reports of the company buying back or selling its own shares (share repurchase/issuance). The document length is substantial and contains detailed transactional data, confirming it is not merely an announcement but a report of transactions.
2023-06-13 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It details numerous repurchases of shares with dates and quantities, confirming compliance with listing rules and legal requirements. The content focuses on share repurchase activities and changes in issued shares, which aligns with announcements regarding the company's transactions in its own shares. There is no indication of financial statements, management discussion, or other report types. The document is lengthy and detailed, not a brief announcement or certification. Therefore, the most appropriate classification is 'Transaction in Own Shares' (POS).
2023-06-12 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.